Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 321
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Ibogaine’s Moment Has Arrived. Are We Ready to Meet It?
The Post-Psychedelic Challenges Study: A Vital New Frontier in Psychedelic Science
Megan Bowers & Mikayla Hellwich: MDMA History, Harm Reduction, and the Problem With Prohibition
Pα+ Psychedelic Bulletin #229: SAMHSA Convenes Experts; AtaiBeckley’s Road to Lilly; Turnbull Doubles Down on BOL-148; Compass Talks Indication Expansion, Could VA Help?
From Sonora to Big Pharma: Kimon de Greef Traces the Strange Rise of 5-MeO-DMT
Psychedelics Show Promise for Treating Dementia
Catching Up with the Psychedelic Entourage Effect: Part 3 – Field...
Insight into Ayahuasca’s Antidepressant Effects
New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
MindMed Upsizes Previously Announced Bought Deal Public Offering
MindMed Announces $50 Million Bought Deal Public Offering
MindMed Announces Successful Completion of Pre-IND Meeting with the FDA for...
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet...
MindMed Files Final Prospectus In Connection With Bought Deal Equity Financing
MindMed Files Preliminary Prospectus In Connection With Bought Deal Equity Financing
Load more